2010/11流感季流感疫苗接种后吉兰-巴雷综合征近实时监测的α消耗计划比较
该研究利用美国医疗保险行政数据和更新序贯概率比检验方法,评估不同α消耗计划在流感疫苗接种后吉兰-巴雷综合征近实时监测中的表现。结果显示,对于相对风险5或以上,几乎所有计划均有100%功效;对于相对风险1.5或以下,恒定计划和O'Brien-Fleming计划功效更高;Pocock计划在相对风险1.5及以上最早发出信号,但在相对风险1.25时不发出信号;恒定α消耗计划在不同参数下表现稳健。
要点
- 对于相对风险5或以上,几乎所有α消耗计划均有100%功效。
- 对于相对风险1.5或以下,恒定计划和O'Brien-Fleming计划功效更高。
- 恒定α消耗计划在功效和信号检测时间上对不同参数表现稳健。
核心结论
- 恒定α消耗计划在功效和检测信号时间方面,在包括基于累积疫苗接种或观察到的GBS索赔的替代监测开始日期、监测频率、假设相对风险和疫苗 uptake 模式等一系列参数下表现稳健。
研究设计与样本
- 使用美国医疗保险行政数据和更新序贯概率比检验方法以考虑索赔延迟,通过改变多个参数评估了多种不同的α消耗计划。
主要发现
- 对于相对风险5或以上,几乎所有α消耗计划均有100%功效;对于相对风险1.5或以下,恒定计划和O'Brien-Fleming计划功效越来越高。
- 对于相对风险1.5及以上,Pocock计划最早发出信号,但在相对风险1.25时不会发出信号,如先前流感季所观察到的。
- 在由疫苗接种数量定义的监测开始日期方面,不同计划之间没有显著差异;减少 interim 检测次数仅略微改善性能。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Near real-time surveillance of the influenza vaccine, which is administered to a large proportion of the US population every year, is essential to ensure safety of the vaccine. For efficient near real-time surveillance, it is key to select appropriate parameters such as monitoring start date, number of interim tests and a scheme for spending a pre-defined total alpha across the entire influenza season. Guillain-Barré Syndrome, shown to be associated with the 1976 influenza vaccine, is used to evaluate how choices of these parameters can affect whether or not a signal is detected and the time to signal. FDA has been monitoring for the risk of GBS after influenza vaccination for every influenza season since 2008. METHODS: Using Medicare administrative data and the Updating Sequential Probability Ratio Test methodology to account for claims delay, we evaluated a number of different alpha-spending plans by varying several parameters. RESULTS: For relative risks of 5 or greater, almost all alpha-spending plans have 100% power; however, for relative risks of 1.5 or lower, the constant and O'Brien-Fleming plans have increasingly more power. For RRs of 1.5 and greater, the Pocock plan signals earliest but would not signal at a RR of 1.25, as observed in prior influenza seasons. There were no remarkable differences across the different plans in regards to monitoring start dates defined by the number of vaccinations; reducing the number of interim tests improves performance only marginally. CONCLUSIONS: A constant alpha-spending plan appears to be robust, in terms of power and time to detect a signal, across a range of these parameters, including alternate monitoring start dates based on either cumulative vaccinations or GBS claims observed, frequency of monitoring, hypothetical relative risks, and vaccine uptake patterns.
引用
- Sandhu SK, Hua W, MaCurdy TE, et al. Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré Syndrome after influenza vaccination during the 2010/11 influenza season. Vaccine. 2020. PMID: 31932134. doi:10.1016/j.vaccine.2019.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。